oxazolidin-2-one has been researched along with Cirrhoses, Experimental Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alegre, F; Banales, JM; Barbero, R; Carreño, N; Chang, HC; García, M; Herrero, I; Morán, A; Pérez-Vizcaíno, F; Prieto, J; Quiroga, J; Reboredo, M; Rodríguez-Ortigosa, CM; Sangro, B | 1 |
| Bae, SK; Kim, EJ; Kim, WB; Kwon, JW; Lee, I; Lee, MG | 1 |
2 other study(ies) available for oxazolidin-2-one and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Body Weight; Carbon Tetrachloride; Catecholamines; Common Bile Duct; Cyclic AMP; Drug Synergism; Drug Therapy, Combination; Hypertension, Portal; Infusions, Intravenous; Ligation; Liver Cirrhosis, Experimental; Lypressin; Mesenteric Artery, Superior; Oxazolidinones; Perfusion; Portal Pressure; Propranolol; Rats; Regional Blood Flow; Renal Artery; Splanchnic Circulation; Sympathectomy; Terlipressin; Tryptamines; Vasodilation | 2013 |
Excretion and metabolism of DA-7867, a new oxazolidinone, in rats.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Dimethylnitrosamine; Enzyme Inhibitors; Feces; Injections, Intravenous; Liver Cirrhosis, Experimental; Male; Metabolic Clearance Rate; Oxazolidinones; Proadifen; Rats; Rats, Sprague-Dawley; Tail; Time Factors; Tissue Distribution | 2005 |